Tirzepatides dual agonism of GIP and GLP-1 receptors allows for enhanced glycemic control and appetite regulation
A first-of-its-kind study This study was investigator-led, meaning it was conducted independently, without involvement from any pharmaceutical companies
In some cases, degraded medication may trigger unexpected allergic or sensitivity reactions, even in individuals who previously tolerated the medication well
References 1 ArakawaM.MitaT.AzumaK.EbatoC.GotoH.NomiyamaT.et al (2010)
The Big Picture Despite the potential for side effects like gastroparesis and SIBO, semaglutide offers huge benefits
Hepatic (liver) function : Similarly, no dose adjustment is required for patients with hepatic impairment, including those with severe liver disease